HELENA, Mont. — When Lou and Lindsay Volpe’s son was diagnosed with a chronic bowel disease at age 11, their health insurer required constant preapproval of drugs and treatments — a process the Volpes say often delayed critical care for their son. “You subscribe to your insurance policy, you pay into that for years and…
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high. But lawmakers and the second-term governor are at odds over what to do about it, and a recent proposal could trigger one of the biggest health care battles in Sacramento this year. A California bill awaiting its…
In Arkansas, state health officials announced a stunning statistic for 2023: The total number of abortions in the state, where some 1.5 million women live, was zero. In South Dakota, too, official records show zero abortions that year. And in Idaho, home to abortion battles that have recently made their way to the U.S. Supreme…
This analysis examines the potential impacts on states and Medicaid enrollees of eliminating the 90% federal match rate for the Affordable Care Act (ACA) expansion. Eliminating the federal match rate for adults in the Medicaid expansion could reduce Medicaid spending by nearly one-fifth ($1.9 trillion) over a 10-year period and up to nearly a quarter…
House Republicans introduced a proposal seeking to cut Medicaid spending by hundreds of billions of dollars. Healthcare leaders are slamming the budget plan, highlighting that it would result in millions of people losing coverage, as well as a surge in uncompensated care for providers. The post GOP Seeks to Drastically Cut Medicaid Spending — How…
That is the subtitle of a paper by Vreman et al. (2020). The authors look at all treatments approved by FDA and EMA that were subsequently reviewed by HTA bodies in both jurisdictions between 1995 and 2018. The authors used ICER as the US HTA body; European HTA bodies included IQWiG (Germany), NICE (UK), ZIN…
Platform aims to create a multi-functional, rugged electric vehicle platform to deliver hospital-level care in rural communities across the country
Smaller healthcare providers need support rather than being threatened with penalties, cybersecurity expert says
SpringWorks Therapeutics’ Gomekli is now FDA approved for treating tumors caused by the rare genetic disorder neurofibromatosis type 1. The approval comes as SpringWorks has emerged as a potential acquisition target. The post FDA Approval of Drug for Rare Tumors Enables SpringWorks to Challenge AstraZeneca appeared first on MedCity News.
Harnessing AI to Enhance Efficiency In Healthcare Technology Management Healthcare Technology Management (HTM) is evolving rapidly, and artificial intelligence (AI) is at the forefront of this transformation. By integrating AI into our CMMS, we’re exploring new ways to enhance operations, improve efficiency, and deliver better outcomes for healthcare facilities. These advancements reflect our dedication to…